Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  BIOTERRORISM
A Global Strategic Business Report

This report analyzes the worldwide markets for Bioterrorism in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, Asia, and Middle East. Annual forecasts are provided for each region for the period of 2001 through 2015. The report profiles 66 companies including many key and niche players worldwide such as Acambis Plc., AVI BioPharma, Inc., Blücher Gmbh, Evogen, Inc., Human Genome Sciences Inc., ICX Technologies, Inc., ILC Dover LP, Medarex, Inc., Northrop Grumman Corporation, PharmAthene, Inc., Scott Health & Safety, Smiths Detection, The Baker Company, Universal Detection Technology and Universal Detection Technology. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1831  PAGES:    273
PRICE:    $3950  DATE:       July 2009
COMPANIES:  66  MARKET DATA TABLES:   97
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  BIOTERRORISM (Complete Report) Pages : 273   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS3$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
II. EXECUTIVE SUMMARY43$2250
  1. INTRODUCTION.....II-12 $200  
   Current & Future Analysis.....II-1
Market Overview.....II-1
2$200
  2. UNDERSTANDING BIOTERRORISM.....II-314 $850  
   A Brief Historic Account on Bioterrorism.....II-31$100
   Why Biological Agents?.....II-4
An Ideal Biological Weapon Candidate.....II-4
Bioterrorism is Easy: The Myth!.....II-4
Biological Agents/Diseases with Potential for Biological Warfare.....II-4
1$100
   Properties of Biological Agents with Potential for Use as Weapons of Mass
  Destruction.....II-5
1$100
   Anthrax.....II-6
The Anthrax History.....II-6
1$100
   Types of Anthrax.....II-7
Inhalational Anthrax.....II-7
Cutaneous Anthrax.....II-7
Gastrointestinal Anthrax.....II-7
The Anthrax Symptoms, Treatment, and Vaccination.....II-7
1$100
   Smallpox.....II-8
The Smallpox History.....II-8
1$100
   Plague.....II-9
The Plague History.....II-9
Types of Plague.....II-9
Bubonic Plague.....II-9
1$100
   Pneumonic Plague.....II-10
Botulism.....II-10
1$100
   Tularemia.....II-111$100
   The Tularemia History.....II-12
Viral Hemorrhagic Fevers.....II-12
Ebola Hemorrhagic Fever.....II-12
1$100
   Marburg Hemorrhagic Fever.....II-13
Lassa Hemorrhagic Fever.....II-13
1$100
   Q Fever.....II-141$100
   Brucellosis.....II-151$100
   Ricin.....II-16
Others.....II-16
1$100
  3. MODES OF DELIVERY.....II-172 $200  
   Aerosol Dissemination.....II-17
Water Contamination.....II-17
Food Contamination.....II-17
Insect Vectors.....II-17
1$100
   Other.....II-18
1$100
  4. BIOTERRORISM DEFENSE PRODUCTS AND DETECTION EQUIPMENT.....II-192 $200  
   Detection Equipment.....II-19
Point Detection Systems.....II-19
Standoff Detection Systems.....II-19
Passive Standoff Detection Systems.....II-19
Defense Products.....II-19
Vaccines.....II-19
1$100
   Personal Protective Equipment.....II-20
1$100
  5. RECENT INDUSTRY ACTIVITY.....II-2114 $850  
   Sanofi Pasteur Acquires Acambis.....II-21
PharmAthene Acquires Avecia Biodefense Vaccines Business.....II-21
ICx Technologies Completes S3I Acquisition.....II-21
1$100
   Johnson & Johnson to Acquire Omrix.....II-22
Emergent BioSolutions Enters into Joint Venture with Ninebio Sdn Bhd.....II-22
Alert B&C, Frontline Robotics, and Dragon Securite Sign MoU.....II-22
1$100
   Universal Detection and Kadinuo Sign Agreement.....II-23
PharmAthene Signs Marketing Pact with Medison for Israeli Market.....II-23
PharmAthene Forms Alliance with Panacea Biotec.....II-23
1$100
   Innovative Biosensors and Universal Detection Plan Collaboration.....II-24
Acambis Wins Government Contract for ACAM2000™ Smallpox Vaccine.....II-24
Crucell, Integrated BioTherapeutics Win NIAID Funding for Vaccine Development.....II-24
1$100
   Universal Detection Secures Repeat Order for Biodetection Kits.....II-25
Universal Detection Secures Repeat Order for Biodetection Training Equipment.....II-25
Universal Detection Secures and Completes Contract.....II-25
1$100
   Hawaii Emergency Medical Services Orders Simulation and Bio-Detection Kits.....II-26
IR BioSciences Raises Financing for Drug Development.....II-26
AVI BioPharma Files IND for Marburg.....II-26
ICx Technologies Completes GHC Technologies Acquisition.....II-26
1$100
   NanoSensors to Acquire DKL International.....II-27
Allen-Vanguard to Acquire Hazard Management Solutions.....II-27
PharmAthene Announces Reverse Merger to Acquire Healthcare Acquisition.....II-27
1$100
   CytoGenix Enters into CRADA with USAMRIID.....II-28
Advanced Life Sciences Announces Collaboration with NIAID.....II-28
U.S. BioDefense to Receive Exclusive License from Shine Holdings.....II-28
1$100
   Emergent BioSolutions Signs Agreement to License VaxImmune.....II-29
Universal Detection Signs Distribution Agreement with ADVNT.....II-29
Universal Detection Secures Gulf Security Order for Detection Kits.....II-29
Dycor Technologies Wins Rheinmetall Landsystems Contract.....II-29
1$100
   AVI BioPharma Secures Bioterrorism Response Therapies Contracts.....II-30
Emergent BioSolutions Wins HHS Anthrax Biodefense Contract.....II-30
Nanotherapeutics Wins Anti-Bioterrorism Drug Contract from NIAID/ BARDA.....II-30
1$100
   SRI International Secures Contract for Anti-Biological Threat Drugs from DTRA.....II-31
Universal Detection Completes Foot Locker Order for Bioterrorism Detection
  Kits.....II-31
PharmAthene Wins HHS Biodefense Contract.....II-31
1$100
   Ibis Biosciences Receives Four New Contracts from Government.....II-32
Universal Detection Receives Guaranteed Order from SSI.....II-32
Ichor Receives Navy Contract for Vaccine Development.....II-32
1$100
   PharmAthene Receives Contract to Develop Anthrax Anti-Toxin.....II-33
General Dynamics Canada Secures Contract from Canadian Forces.....II-33
1$100
   Universal Detection Commences R&D for Portable Anthrax Detector.....II-34
BioFactura Completes Initial Clinical Testing.....II-34
1$100
  6. PRODUCT LAUNCHES.....II-352 $200  
   Smiths Detection Introduces SmartBio™ Biological Agents Detector.....II-35
Safe Life Launches Triosyn Disposable Respirators.....II-35
ICx Unveils Integrated System for CBR Threat Detection, SafeAir™.....II-35
1$100
   Innovative Biosensors Unveils BioFlash Biological Detector.....II-36
Lawrence Laboratory Develops Biological, Chemical Agent Detection Machine.....II-36
1$100
  7. FOCUS ON SELECT PLAYERS.....II-375 $350  
   Acambis Plc (UK).....II-37
AVI BioPharma, Inc. (USA).....II-37
Blücher Gmbh (Germany).....II-37
Evogen, Inc. (USA).....II-37
1$100
   Human Genome Sciences Inc. (USA).....II-38
ICX Technologies, Inc. (USA).....II-38
ILC Dover LP (USA).....II-38
1$100
   Medarex, Inc. (USA).....II-39
Northrop Grumman Corporation (USA).....II-39
PharmAthene, Inc. (USA).....II-39
1$100
   Scott Health & Safety (USA).....II-40
Smiths Detection (USA).....II-40
The Baker Company (USA).....II-40
1$100
   Universal Detection Technology (USA).....II-41
1$100
  8. GLOBAL MARKET PERSPECTIVE.....II-42   
   Table 1: World Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment by Geographic Region – US, Europe, Asia (Including Japan), and Middle East Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-421$300
   Table 2: World Historic Review for Bioterrorism Detection Equipment by Geographic Region – US, Europe, Asia (Including Japan), and Middle East Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2001 through 2015 (includes corresponding Graph/Chart).....II-43

Table 3: World 10-Year Perspective for Bioterrorism Detection Equipment Market by Geographic Region – Percentage Share Breakdown of Dollar Revenue for US, Europe, Asia (Including Japan), and Middle East Markets for Years 2006, 2009, and 2015 (includes corresponding Graph/Chart).....II-43
1$300
III. MARKET22$1950
  1. THE UNITED STATES.....III-116 $1175  
   A. Market Analysis.....III-1
A Case of Undue Importance.....III-1
1$75
   Market Drivers.....III-2
Market Dampers.....III-2
Investment Bottlenecks.....III-2
Legislative Bottlenecks.....III-2
1$75
   Government Biodefense Funding.....III-3
The Federal Biological Weapons Prevention and Defense Funding.....III-3
1$75
   Table 4: The US Federal Government Spending on Bioweapons Prevention and Defense – Allocation of Funds in US$ Million by Department/Agency from FY2001 to FY2007 (includes corresponding Graph/Chart).....III-41$150
   Table 5: The US Federal Government Spending on Bioweapons Prevention and Defense – Percentage Share Breakdown of Funds Allocation by Department/Agency for FY2001 and FY2007 (includes corresponding Graph/Chart).....III-51$150
   Table 6: The US Federal Funding for the Department of Health and Human Services by its Constituent Agencies and Offices in US$ Million from FY2001-FY2007 (Including Requested Funding for the Year 2007) (includes corresponding Graph/Chart).....III-6
The RDT&E Biodefense Funding.....III-6
1$150
   Table 7: Biodefense Funding for Research, Development, Testing and Evaluation (RTD&E) by Agency/Department in US$ Million from FY2001 to FY2007.....III-71$150
   Biodefense Prevention Funding.....III-8
Table 8: Federal Biodefense Prevention Funding in US$ Million from FY2001 to FY2007 (includes corresponding Graph/Chart).....III-8
Recent Awards for Biodefense Preparedness.....III-8
1$150
   Government Biodefense Initiatives.....III-9
Project BioShield.....III-9
1$75
   Pandemic and All-Hazards Preparedness Act.....III-10
Public Health Security and Bioterrorism Preparedness and Response Act.....III-10
Government Departments / Agencies.....III-10
The Department of Health and Human Services.....III-10
1$75
   The National Institutes of Health.....III-11
The Centers for Disease Control and Prevention.....III-11
The CDC Classification.....III-11
2$150
   The CDC Regulated Shipment Agents.....III-131$75
   The Department of Defense.....III-141$75
   B. Market Analytics.....III-15
Table 9: US Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-15

Table 10: US Historic Review for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-15
1$150
   Table 11: US Recent Past, Current & Future Analysis for Bioterrorism Vaccines Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-16

Table 12: US Historic Review for Bioterrorism Vaccines Market – Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-16
1$150
  2. EUROPE.....III-172 $225  
   Market Analysis.....III-17
Table 13: European Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-17
1$150
   Table 14: European Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-18
1$150
  3. ASIA.....III-192 $150  
   A. Market Analysis.....III-19
ASEAN and Canada Forge Ties to Combat Bioterrorism.....III-19
China Plans Counter-bioterrorism Security System.....III-19
1$75
   B. Market Analytics.....III-20
Table 15: Asian Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-20

Table 16: Asian Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-20
1$150
  4. THE MIDDLE EAST.....III-212 $300  
   Market Analysis.....III-21
Table 17: The Middle East Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-21
1$150
   Table 18: The Middle East Historic Review for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-221$150
IV. COMPETITIVE LANDSCAPE 198$995
  
Total Companies Profiled: 66 (including Divisions/Subsidiaries - 67)

Region/Country                 Players


The United States                 46 
Canada                             4
Europe                             9
     France                        4
     Germany                       1
     The United Kingdom            1 
     Rest of Europe                3
Asia-Pacific (Excluding Japan)     4  
Middle East                        4
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.